Giovanella L - Search Results

1

The "reset button" revisited: why high activity ¹³¹I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.

Verburg FA, Luster M, Giovanella L, Lassmann M, Chiesa C, Chouin N, Flux G; EANM Thyroid, Radiation Protection and Dosimetry Committees. Verburg FA, et al. Among authors: giovanella l. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):915-917. doi: 10.1007/s00259-017-3649-9. Epub 2017 Feb 16. Eur J Nucl Med Mol Imaging. 2017. PMID: 28210770 No abstract available.

2

Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients.

Verburg FA, Wäschle K, Reiners C, Giovanella L, Lentjes EG. Verburg FA, et al. Among authors: giovanella l. Horm Metab Res. 2010 Sep;42(10):736-9. doi: 10.1055/s-0030-1254132. Epub 2010 May 19. Horm Metab Res. 2010. PMID: 20486066

3

Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.

Giovanella L, Suriano S, Ceriani L, Verburg FA. Giovanella L, et al. Nuklearmedizin. 2010;49(6):N66-8. Nuklearmedizin. 2010. PMID: 21140033 No abstract available.

4

Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan.

Giovanella L, Suriano S, Ceriani L, Verburg FA. Giovanella L, et al. Clin Nucl Med. 2011 Feb;36(2):109-12. doi: 10.1097/RLU.0b013e318203bb84. Clin Nucl Med. 2011. PMID: 21220971

5

Ruling out 131I ablation in low-risk differentiated thyroid carcinoma basing on thyroglobulin measurement.

Giovanella L, Verburg FA. Giovanella L, et al. Thyroid. 2011 Jul;21(7):809-10; author reply 811-2. doi: 10.1089/thy.2010.0435. Epub 2011 May 26. Thyroid. 2011. PMID: 21615306 No abstract available.

6

Thyroid remnant estimation by Tc-99m-sestamibi scanning predicts the effectiveness of rhTSH-stimulated I-131 ablation in patients with differentiated thyroid carcinoma.

Giovanella L, Suriano S, Castellani M, Ceriani L, Verburg FA. Giovanella L, et al. Clin Nucl Med. 2011 Sep;36(9):781-5. doi: 10.1097/RLU.0b013e31821a29eb. Clin Nucl Med. 2011. PMID: 21825849

7

Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.

Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA. Giovanella L, et al. Head Neck. 2012 May;34(5):626-31. doi: 10.1002/hed.21791. Epub 2011 Aug 17. Head Neck. 2012. PMID: 21850699

8

Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.

Giovanella L, Toffalori E, Ceriani L, Caputo M, Verburg FA. Giovanella L, et al. Horm Metab Res. 2011 Sep;43(10):728-30. doi: 10.1055/s-0031-1285868. Epub 2011 Sep 19. Horm Metab Res. 2011. PMID: 21932179

9

Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.

Giovanella L, Toffalori E, Tozzoli R, Caputo M, Ceriani L, Verburg FA. Giovanella L, et al. Head Neck. 2012 Oct;34(10):1369-71. doi: 10.1002/hed.21933. Epub 2011 Nov 15. Head Neck. 2012. PMID: 22083639

10

Thyroid volume influences serum calcitonin levels in a thyroid-healthy population: results of a 3-assay, 519 subjects study.

Giovanella L, Imperiali M, Ferrari A, Palumbo A, Lippa L, Peretti A, Graziani MS, Castello R, Verburg FA. Giovanella L, et al. Clin Chem Lab Med. 2012 Apr 4;50(5):895-900. doi: 10.1515/cclm-2011-0920. Clin Chem Lab Med. 2012. PMID: 22628334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page